Espumisan drops and capsules | use | side effects and more

Espumisan is a drug that contains an active substance called simethicone. This drug works by decomposing accumulated gas in the stomach and helps its elimination.

It is used to relieve symptoms in patients with bloating (flatulence) and meteorism, as well as for diagnostic purposes in examining the digestive tract.


Before you start using this medicine, doctor should examine your digestive tract, in order to identify the cause of stomach problems.

It should be avoided in patients allergic to active substance simethicone.

Use of Espumisan during pregnancy and breastfeeding

There is insufficient data on the use during pregnancy, but it is considered that this drug is completely safe for use in pregnancy and breastfeeding.

Espumisan dose and use

  • It is found in the form of drops and capsules.
  • Espumisan drops can be applied in babies, even in infants.

It should be applied as follows:




How to use
Infants (0-12 months) 25 drops per day.

It is recommended to use 8 drops three times a day (every 8 hours). Add drops into the feeding bottle and give this to your baby before each breastfeeding.

Children aged between 1-6 years



25 drops, 3 to 5 times a day.


Children aged between 6-14 years



25-50 drops, 3 to 5 times a day.



Espumisan capsules can be used to patients above the age 6 (two capsules 3-4 times a day).

There are no reported cases of overdose because this medicament is very well tolerated.

Use with other medicines (Interactions)

There are no known interactions with other drugs. Drops and capsules can be used regardless of what drugs patients are already taking.

Espumisan side effects

Espumisan drops and capsules are well tolerated and so far there are no reported side effects. However, like all other substances and this drug may cause an allergic reaction. If you are experiencing symptoms of an allergy, such as:

  • redness,
  • swelling of the face,
  • swelling of the tongue and difficulty breathing, contact your doctor immediately.


Comments are closed.